NEW YORK, September 25, 2018 /PRNewswire/ --
The bioinformatics market is estimated to reach USD 19.79 billion by 2026, according to the latest study by Aftrex Market Research. Large investments from key players towards the development of bioinformatics solutions is expected to propel the market growth.
Access complete report along with TOC on "Bioinformatics Market Analysis and Segment Forecasts To 2026" at https://www.aftrexmarketresearch.com/report-details.php?id=1139
Drug Discovery & Chemoinformatics application segment to register highest CAGR
The use of machine learning in drug design is expected to drive the market growth over the forecast period. Machine learning enables drug designers to easily procure chemical information from large compound database and perform various analysis required for drug manufacturing process. Moreover, it also helps researchers to understand correlation between chemical composition and their biological activities.
Asia Pacific region is expected to witness highest growth over the forecast period
A large number of healthcare investments in the Asia Pacific region is expected to drive the bioinformatics market. Furthermore, the high adoption of IoT technologies in this sector is also expected to positively impact market growth in the region. Key countries including China and India are expected to largely propel the bioinformatics market in this region.
Key players operating in the market comprise Thermo Fisher Scientific, Eurofins Scientific, Illumina, Perkinelmer, Inc., Qiagen Bioinformatics, Agilent Technologies, Dnastar, Waters Corporation, Sophia Genetics, Partek, Biomax Informatics AG, Wuxi Nextcode, and Beijing Genomics Institute (BGI) among others.
For the purpose of this study, Aftrex Market Research has segmented the bioinformatics market based on products/tools & services, application, end-use, and region:
Bioinformatics Products/Tools & Services Scope (Revenue, USD Billion; 2014 - 2026)
- Knowledge Management
- Data Analysis
Bioinformatics Application Scope (Revenue, USD Billion; 2014 - 2026)
- Drug Discovery & Chemoinformatics
Bioinformatics End-use Scope (Revenue, USD Billion; 2014 - 2026)
Bioinformatics Regional Scope (Revenue, USD Billion; 2014 - 2026)
- North America
- Asia Pacific
- Latin America
Browse related reports
- Therapeutic Drug Monitoring Market: https://aftrexmarketresearch.com/report-details.php?id=1135
- Smart Healthcare Market: https://www.aftrexmarketresearch.com/report-details.php?id=1047
- Healthcare Predictive Analytics Market: https://www.aftrexmarketresearch.com/report-details.php?id=995
About Aftrex Market Research
Aftrex Market Research is a research and consulting company that provides consulting services, syndicated & customized research reports. Our services & reports are instrumental in helping clients to make effective and informed business decisions. We offer market intelligence studies that comprise facts-based relevant data for various industries including chemicals, food & beverages, energy, healthcare, technology, and materials. With a deep understanding of various industries, Aftrex Market Research provides strategic insights based on monitoring and analyzing the market to predict its current scenario and future growth prospects. For more information, visit https://www.aftrexmarketresearch.com/
Mark Geoffry (Corporate Sales)
Aftrex Market Research
Connect with us on LinkedIn: https://www.linkedin.com/company/aftrex-market-research/